Wedge Capital Management’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-166,573
Closed -$1.21M 543
2026
Q1
$1.21M Buy
166,573
+60,407
+57% +$547K 0.02% 419
2025
Q4
$1.02M Buy
106,166
+1,140
+1% +$11.8K 0.02% 425
2025
Q3
$1.28M Buy
+105,026
New +$1.1M 0.02% 405
2019
Q4
Sell
-5,557
Closed -$236K 584
2019
Q3
$236K Sell
5,557
-3,462
-38% -$145K ﹤0.01% 519
2019
Q2
$445K Buy
9,019
+2,276
+34% +$116K 0.01% 474
2019
Q1
$323K Buy
6,743
+864
+15% +$52.4K ﹤0.01% 513
2018
Q4
$361K Sell
5,879
-132
-2% -$8.9K ﹤0.01% 471
2018
Q3
$495K Buy
6,011
+488
+9% +$38.8K ﹤0.01% 466
2018
Q2
$432K Buy
5,523
+114
+2% +$8.83K ﹤0.01% 483
2018
Q1
$399K Sell
5,409
-537
-9% -$38.1K ﹤0.01% 479
2017
Q4
$406K Sell
5,946
-661
-10% -$42.8K ﹤0.01% 477
2017
Q3
$406K Sell
6,607
-285
-4% -$17.5K ﹤0.01% 476
2017
Q2
$433K Sell
6,892
-2,170
-24% -$124K ﹤0.01% 461
2017
Q1
$503K Buy
+9,062
New +$467K ﹤0.01% 435

Other funds holding NUS

Wedge Capital Management's NUS Position: Q2 2026 in Review

Wedge Capital Management sold out of Nu Skin (NUS) in Q2 2026, closing a stake of 166,573 shares — an estimated $1.21M sold.

Wedge Capital Management first reported a position in NUS in Q1 2017 and held it in 14 quarters. The position peaked at $1.28M in Q3 2025. 7 funds tracked by Wall St. Rank hold NUS as of Q2 2026.

  • Wedge Capital Management reported no remaining Nu Skin position as of Q2 2026 after selling out during the quarter.
  • Wedge Capital Management sold 166,573 Nu Skin shares in Q2 2026, an estimated $1.21M.
  • Wedge Capital Management first reported a position in Nu Skin in Q1 2017 and held it in 14 quarters.
  • Wedge Capital Management's Nu Skin position peaked at $1.28M in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Nu Skin as of Q2 2026.

Based on Wedge Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.